Last reviewed · How we verify
Precedex
At a glance
| Generic name | Precedex |
|---|---|
| Also known as | dexmedetomidine hydrochloride injection, Dexmedetomidine, IV Precedex, precedex, dexmedetomidine |
| Sponsor | Helsinki University Central Hospital |
| Target | Alpha-1A adrenergic receptor, Alpha-1B adrenergic receptor, Alpha-1D adrenergic receptor |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
- Conscious sedation
Common side effects
- Hypotension
- Bradycardia
- Hypertension
- Nausea
- Dry Mouth
- Vomiting
- Fever
- Hypoxia
- Tachycardia
- Atrial Fibrillation
- Anemia
- Hemorrhage
Serious adverse events
- Hypotension Requiring Intervention
- Bradycardia Requiring Intervention
- Pulmonary Edema
- Ventricular Tachycardia
- Atelectasis
- Hypovolemia
- Post-procedural Hemorrhage
Key clinical trials
- Effect of Lidocaine Infusion Versus Dexmedemidine Infusion on the Neurocognitive Function of Elderly Patients Undergoing Endoscopic Retrograde Cholangiopancreatography(ERCP): a Randomized, Controlled Trial. (NA)
- Dexmedotomidine for Acute Pain Control in Patients With Multiple Rib FracturesRandomized Controlled Trial (PHASE4)
- Using Lidocaine or Dexmedetomidine to Help Control Blood Pressure Spikes From a Tourniquet During Knee Surgery (PHASE2)
- The Effects of Dexmedetomidine on Postoperative Cognitive Function in Open Heart Surgery (NA)
- Dexmedetomidine Use in Infants Undergoing Cooling Due to Neonatal Encephalopathy (DICE Trial) (PHASE2)
- PENG Block With Dexmedetomidine in Older Adults (NA)
- Comparison Between Total Intravenous Anesthesia With Magnesium Sulphate Versus Total Intravenous Anesthesia With Dexmedetomidine in Patients Undergoing Lumbar Spine Surgeries (PHASE3)
- Dexmedetomidine-Midazolam vs. Ketamine-Midazolam on Emergence Delirium (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |